|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61P 35/00 | |||
| A61K 47/68 | |||
| A61K 39/395 |
| (11) | Number of the document | 3036257 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14761739.3 |
| Date of filing the European patent application | 2014-08-20 | |
| (97) | Date of publication of the European application | 2016-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/051831 |
| Date | 2014-08-20 |
| (87) | Number | WO 2015/026907 |
| Date | 2015-02-26 |
| (30) | Number | Date | Country code |
| 201361868185 P | 2013-08-21 | US | |
| 201462012440 P | 2014-06-16 | US | |
| 201462026088 P | 2014-07-18 | US |
| (72) |
PAPADOPOULOS, Nicholas, US
THURSTON, Gavin, US
KIRSHNER, Jessica, US
KELLY, Marcus, US
NITTOLI, Thomas, US
DELFINO, Frank, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ANTI-PRLR ANTIBODIES AND USES THEREOF |
| ANTI-PRLR ANTIBODIES AND USES THEREOF |